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Edited by Maurice MontalAbstract CLC chloride channels are a family of channel pro-
teins mediating chloride transport across the plasma membrane
and intracellular membranes. The single yeast CLC protein
Gef1p is localized to the Golgi and endosomal system. Investi-
gating epitope-tagged variants of Gef1p, we found that the chan-
nel is proteolytically processed in the secretory pathway.
Proteolytic cleavage occurs in the ﬁrst extracellular loop of the
protein at residues KR136/137 and is carried out by the Kex2p
protease. Fragments mimicking the N- and C-terminal products
of the cleavage reaction are non-functional when expressed
alone. However, functional channels can assemble when the
two fragments are co-expressed.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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CLC proteins are chloride ion channels associated with a
broad spectrum of physiological functions [1]. Of the nine
CLC homologues present in mammalian organisms ﬁve
channels are mainly or exclusively localized to intracellular
membranes, where they contribute to the ionic composition
of the luminal compartment, particularly to endosomal and
lysosomal acidiﬁcation. Vesicle traﬃcking connects the dif-
ferent membrane-enclosed compartments. Thus, ion trans-
port activities must be exquisitely regulated to maintain
diﬀerences in ion composition between diﬀerent organelles
like the endoplasmic reticulum (ER), the Golgi apparatus,
and the endo-lysosomal system. For CLC channels, this reg-
ulation is poorly understood but likely comprises high-ﬁdel-
ity sorting processes as well as functional regulation of these
proteins.
We have chosen the single CLC protein present in the
yeast Saccharomyces cerevisiae [2] as a model to investigate
the sorting and regulation of CLC channels present in the
Golgi and endosomal system. Inactivation of the CLC
(GEF1) gene in yeast has been shown to result in two main
phenotypes: loss of high aﬃnity iron uptake and reduced*Corresponding author. Fax: +49 6221 545894.
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(B. Schwappach).
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doi:10.1016/j.febslet.2005.01.011resistance to toxic cations [2–4]. High-aﬃnity iron uptake
is lost because Fet3p (an oxidase involved in high aﬃnity
iron uptake at the cell surface) does not mature normally
in Dgef1 strains. Copper loading to the active centre of
Fet3p in the lumen of the late secretory pathway requires
Cl ions that enter the compartment via the CLC channel
[5]. The sequestration of toxic cations is presumably aﬀected
because this process depends on anions that can counterbal-
ance the accumulation of positive charge on the luminal
side. The subcellular localization of Gef1p to the Golgi
and prevacuolar compartments [4,6] is consistent with the
functions suggested by the knockout phenotypes. However,
we report here that there is an additional level of complexity
to consider, since the channel protein undergoes proteolytic
processing in the secretory pathway.2. Materials and methods
2.1. Yeast strains and media
Standard yeast media and genetic manipulations were as described
[7]. LIM50 low iron selection medium was prepared as described [8].
Where indicated methionine was omitted from the media to allow
for maximal expression from plasmids containing the MET25 pro-
moter [9]. The Dgef1 deletion strain has been described [4]. The
BY4741-derived Dkex2 strain was obtained from the EUROSCARF
consortium (www.uni-frankfurt.de/fb15/mikro/euroscarf). For com-
parison a Dgef1 strain from EUROSCARF was used for the experi-
ment shown in Fig. 2C.2.2. Molecular biology
Standard molecular biology protocols were adapted from [7]. Epi-
tope-tagged, mutated versions, and GFP fusion constructs of Gef1p
were created using the polymerase chain reaction. Constructs were ver-
iﬁed by sequencing. GFP (S65T) was fused to the N- or C-terminus of
Gef1p using an engineered NotI restriction site replacing the start or
stop codon of the respective open reading frames with three codons
encoding alanine. The 4 protein C (PC) epitope was fused to Gef1p
using the same NotI sites. The sequence of the PC epitope (Roche)
reads EDQVDPRLIDGK. For integrating constructs, plasmids
pRS305 and pRS306 were used [10]. Plasmids containing the MET25
promoter [9] were used when indicated.
2.3. Subcellular fractionation on sucrose gradients
Separation of organelles was performed according to Nass and Rao
[11]. Brieﬂy, cells were grown to mid-logarithmic phase, converted to
spheroblasts and lysed by douncing in a hypotonic buﬀer (0.3 M sor-
bitol, 50 mM triethanol amine, 1 mM EDTA, and 2 mM Mg acetate,
pH 8.9). The homogenate was layered on freshly prepared ten-step su-
crose gradients and centrifuged for 2 h at 23500 rpm in an SW28 rotor
(Beckman). Membranes from the diﬀerent fractions were pelleted by
centrifugation (SW28, 30 min at 23500 rpm). The sucrose concentra-
tion of each fraction was measured using a refractometer.blished by Elsevier B.V. All rights reserved.
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Yeast extracts were prepared from 1.8 OD600 units of log-phase cells
by alkaline lysis and precipitation of total cellular protein by trichloro-
acetic acid. Total extracts or puriﬁed membranes were separated by
SDS–PAGE using 10% or 7% gels and transferred to nitrocellulose.
Blots were blocked in TBS containing 5% milk powder and 0.02%
NP-40. Primary antibodies (anti-PC mouse monoclonal HPC4, Roche,
0.25 lg/ml; anti-Pep12p, Molecular Probes, 0.5 lg/ml) and secondary
antibodies (HRP-conjugated anti-mouse and anti-rabbit antibodies,
Jackson, 1:3000) were diluted in TBS-blocking solution. Washes were
in TBS-blocking solution and then in TBS, 0.02% NP-40. Detection
was performed using the ECL system (Amersham).3. Results
Published data addressing the subcellular localization of the
yeast CLC protein employs overexpression of a C-terminally
GFP-tagged variant [3,4,6,12]. Since localization to the Golgi
and endosomal system can be saturated we wanted to study
Gef1p expressed at endogenous levels. To this end, we created
a number of strains with tagged versions of the open reading
frame under the control of the endogenous promoter of
GEF1. While it was impossible to detect GFP-tagged versions
of Gef1p by Western blotting, immunoprecipitation, FACS
analysis, or microscopy (not shown), these variants did com-
plement the growth defect of the Dgef1 strain on iron-limited
medium (Fig. 1A). The only tagged versions of Gef1p that
we could detect by Western blotting were 4PC–Gef1p and
Gef1p-4PC. Employing these N- or C-terminally PC epitope
tagged variants, we addressed the localization of the protein
by subcellular fractionation on sucrose gradients. To our sur-
prise, we found that the Gef1p chloride channel is proteolyti-
cally processed giving rise to an N-terminal fragment of
30 kDa and a C-terminal fragment of 70 kDa (Fig. 1B).
For the C-terminally tagged version most of the immunoreac-
tivity was found in a band migrating at 70 kDa that was pre-Fig. 1. Gef1p is proteolytically processed. (A) Four tagged versions of Gef1p
under control of the GEF1 promoter. All strains were created using integrati
dilutions of cultures grown to the same density in YPAD are shown on Y
expressing Gef1p–4PC and 4PC–Gef1p in the Dgef1 background under th
spheroblasts and loaded on ten-step sucrose gradients. Membranes were sedim
loaded in each lane followed by Western blotting analysis using the indicatedominantly localized to the membranes containing strong
Pep12p immunoreactivity, a marker for the pre-vacuole. A lar-
ger band of 100 kDa (presumably representing full-length
Gef1p) was observed in the denser fractions of the gradient,
where ER and plasma membrane marker proteins migrated
(not shown). The N-terminally tagged variant of Gef1p was
detected as a 100 and a 30 kDa band, presumably representing
full-length Gef1p and the N-terminal processing product that
is missing from the 70 kDa fragment observed for the C-termi-
nally tagged form.
The recently solved three-dimensional structure of a bacte-
rial CLC homologue [13] provides a basis for the assignment
of transmembrane helices in the ClC-3,4,5 subfamily [14] as
well as Gef1p. The ﬁrst extracellular loop of Gef1p contains
a consensus cleavage motif (KR136,137; Fig. 2A) for the fur-
in-like Kex2p protease present in late Golgi compartments
[15,16]. This di-basic motif is not conserved in the three closest
mammalian homologues ClC-3,4,5 (Fig. 2B). Mutation of the
two basic residues to alanines yielded a variant of Gef1p–4PC
that migrated at around 100 kDa (Fig. 2C) as predicted for
full-length Gef1p–4PC and as observed for a minor fraction
of wildtype Gef1p–4PC (note that this minor species migrated
in the dense fractions of the gradient as shown in Fig. 1B). Al-
most no protein with faster mobility was observed for the mu-
tant form indicating that speciﬁc cleavage of the protein was in
fact abolished by the mutation. Next, we investigated whether
wildtype Gef1p is processed in a Dkex2 knockout strain.
Again, only the 100 kDa form of the tagged protein was ob-
served, migrating at the same position as the KR mutant of
Gef1p from a wildtype extract (Fig. 2C). These ﬁndings dem-
onstrate that speciﬁc proteolytic cleavage of the ﬁrst extracel-
lular loop of Gef1p requires Kex2p.
We wondered whether the non-cleavable mutant form would
complement a Dgef1 knockout strain with respect to the defect
in high-aﬃnity iron uptake (Fig. 3A). This was indeed the casecomplement the growth defect on iron-limiting medium when expressed
ng plasmids containing the GEF1 5 0 and 3 0 untranslated regions. Serial
PAD and LIM50 plates. (B) Subcellular fractionation of yeast cells
e control of the GEF1 promoter. Homogenates were prepared from
ented from the fractions indicated and 5 lg of membrane protein was
d antibodies.
Fig. 2. Gef1p is cleaved by the Kex2p protease in the ﬁrst extracellular loop. (A) Schematic representation of the structural organization of the
membrane-embedded part of CLC channels (adopted from [13]). The putative Kex2p cleavage site (KR) is marked with an arrow. (B) Alignment of
the ﬁrst extracellular loop for Gef1p and the three most related mammalian CLC proteins ClC-3,4,5. Assignment of helices derived from [13] was
performed according to Gentzsch et al. [14]. (C) Mutation of residues KR136,137 in Gef1p to alanines or absence of Kex2p abolish cleavage. Strains
were transformed with plasmids encoding the indicated constructs and grown in SD medium without methionine for induction. Total protein extracts
from identical amounts of cells were resolved by SDS–PAGE and analyzed by anti-PC immunoblotting.
Fig. 3. A non-cleavable mutant of Gef1p is functional. (A) The mutated version of Gef1p–4PC complements the growth defect on iron-limiting
medium when expressed under control of the GEF1 or the MET25 promoter. The GEF1::GEF1–4PC(KR136,137AA) strain was created using
integrating plasmids containing the GEF1 5 0 and 3 0 untranslated regions. Serial dilution of a culture grown in YPAD is shown on YPAD and LIM50
plates. Dgef1 cells were transformed with the empty plasmid p416MET25 or the same plasmid containing the indicated constructs. Transformants
were grown in SD medium lacking uracil to the same density and serial dilutions were spotted on SD and LIM50 plates. (B) Subcellular fractionation
of yeast cells expressing the non-cleavable mutant form of Gef1p–4PC in the Dgef1 background under the control of the GEF1 promoter. Everything
else as described in Fig. 1C. (C) GFP ﬂuorescence patterns of cells transformed with plasmids encoding Gef1p–GFP fusion proteins as indicated.
Nomarski images are shown on the right. Size bar is 10 lm.
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well as mutant Gef1p–GFP overexpressed from an exogenous
promoter. We addressed the sub-cellular localization of the
non-cleavable protein by the fractionation of organelles on a
sucrose gradient (Fig. 3B). Like the products of the cleavage
reaction (Fig. 1), the non-cleavable variant accumulated in
the prevacuole as marked by Pep12p indicating that sortingof the protein to the prevacuole does not depend on cleavage.
The GFP ﬂuorescence pattern of the overexpressed mutant
protein was indistinguishable from the wildtype pattern
(Fig. 3C).
To gain further insight into the possible functional signiﬁ-
cance of the proteolytic processing of Gef1p by Kex2p in
the late Golgi, we expressed proteins engineered to mimic the
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don was introduced to the GEF1 open reading frame at codon
138 to mimic the situation after Kex2p cleavage has taken place
(GEF1DC137). A second protease, Kex1p, is known to further
process Kex2p cleavage products by removing the two basic
residues at the C-terminus of the N-terminal fragment [17].Fig. 4. The individual cleavage products are non-functional but can
co-assemble to yield functional channels. (A) Schematic representation
of the constructs. (B) Complementation assay as described in Fig. 3A
(C) GFP ﬂuorescence patterns of cells transformed with plasmids
encoding Gef1p–GFP fusion constructs as indicated. Nomarski images
are shown on the right. Size bar is 10 lm.Thus, we engineered a second variant of Gef1p with a stop co-
don introduced instead of codon 136 to mimick a possible
Kex1p processing product (GEF1DC135; Fig. 4A). In order
to create a protein similar to the C-terminal fragment of Gef1p
generated by Kex2p, we created a fusion protein of the car-
boxypeptidase Y signal sequence and GFP [18] joined to resi-
due 138 of Gef1p (DNGEF1). All three Gef1p fragments were
tested for complementation of the high-aﬃnity iron uptake
deﬁciency (Fig. 4B). Neither N-terminal nor the C-terminal
fragment was able to complement the growth defect when ex-
pressed alone. In contrast, complementation was observed
when we co-expressed the C-terminal fragment with either N-
terminal fragment indicating that these proteins assemble to
form functional channels. When the GFP ﬂuorescence pattern
of the two N-terminal fragments fused to GFP as well as the C-
terminal fragment was analyzed most of the protein seemed to
reside in the ER (Fig. 4C) as evident from the strong perinu-
clear and cortical staining. This pattern did not change upon
co-expression of the two fragments (not shown) suggesting that
the functional population of channels reaching the late secre-
tory pathway (where Gef1p is thought to aﬀect copper loading
to Fet3p and thus high-aﬃnity iron uptake) may be very small.4. Discussion
Our data demonstrate that the yeast CLC chloride channel
Gef1p is proteolytically processed by the Kex2p protease at po-
sition R137. Consistent with the localization of Kex2p to late
Golgi compartments, the unprocessed form of Gef1p was sep-
arated from the processed form on sucrose gradients whilst the
N- and C-terminal products of the cleavage reaction co-mi-
grated with each other and with a marker of the prevacuolar
compartment. Activation of proteins by proteolytic processing
events late in the secretory pathway is a common regulatory
mechanism. We ﬁnd that Gef1p activity can be restored by
co-expression of fragments resembling the products of the
cleavage reaction. This is consistent with the idea that the split
protein is, indeed, active. Active proteins have been shown to
reassemble from engineered fragments of soluble as well as
membrane proteins and even CLC channels [19,20]. On the
other hand, the non-cleavable form was functional as well as as-
sayed by complementation of the Dgef1 growth phenotype on
iron-limited medium. Thus, cleavage by Kex2p does not repre-
sent a simple on or oﬀ switch for Gef1p channel activity. We are
left with the possibility that cleavage of Gef1p is an erratic by-
product of evolution without any functional signiﬁcance or the
hypothesis that this mechanism may be in place to achieve a
more subtle regulation of the localization or function of Gef1p.
The development of assays with better resolution might make it
possible to distinguish between these alternatives.
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